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A cytotoxic and cytostatic gold(III) corrole
Ruijie D. Teo,ab Harry B. Gray,*a Punnajit Lim,b John Termini,*b Elena Domeshekc
and Zeev Gross*c
We have synthesized and characterized a water-soluble gold(III) corrole
(1-Au) that is highly toxic to cisplatin-resistant cancer cells. Relative to its
1-Ga analogue, axial ligands bind only weakly to 1-Au, which likely
accounts for its lower aﬃnity for human serumalbumin (HSA).We suggest
that the cytotoxicity of 1-Au may be related to this lower HSA aﬃnity.
The seminal report on the scalable synthesis of the first corrole
that is stable in its free-base form, 5,10,15-trispentafluoro-
phenylcorrole,1 was followed one year later by the introduction
of a positively charged derivative as an anti-cancer agent.2 More
recent health-related research has focused on the iron(III),
manganese(III), aluminium(III), and gallium(III) complexes of
2,17-bis-sulfonato-5,10,15-trispentafluorophenylcorrole
(Scheme 1: 1-Fe, 1-Mn, 1-Al, and 1-Ga).3–5
These well characterized amphipolar complexes form tight
conjugates with a variety of proteins that have been used as
traﬃcking and cell penetrating vehicles in physiologically
relevant media.6 Closed-shell metallocorroles have been employed
for optical imaging, whereas certain others exhibit pro-oxidant,
anti-oxidant, and cell-killing properties, as follows: 1-Mn catalyzes
the peroxidase-like enantioselective oxidation of sulfides by hydro-
gen peroxide,7 1-Fe is the best synthetic catalyst reported to date for
the catalase-like decomposition of hydrogen peroxide to water and
molecular oxygen,8 1-Al is a versatile optical imaging agent,9 and
1-Ga is cytotoxic to breast cancer cells.10 What distinguishes corroles
from most other ligands is that none of its metal-ion derivatives is
demetallated under physiologically relevant conditions.11
During the last decade, several gold(I) and gold(III) compounds
were reported tomanifest impressive antitumor properties, making
up a promising class of experimental anticancer agents.12 Among
these agents, a cytotoxic gold(III) porphyrin complex, [Au(TPP)]Cl,
was found to be particularly active, as it blocked the self-renewal
ability of cancer stem-like cells.13 Most notably, [Au(TPP)]Cl was
neither demetallated nor reduced during circulation in biological
media. This key finding stimulated our interest in gold(III) corroles,
which are redox-stable, low-spin square planar complexes, and
similar to gold(III) porphyrins and platinum(II) anticancer drugs
such as cisplatin.14
Here we report a water-soluble gold(III) complex of 2,17-bis-
sulfonato-5,10,15-trispentafluorophenylcorrole (1-Au): we have
studied its association with human serum albumin (HSA), themost
abundant (and potential drug transporting) protein present in
plasma.15 In the course of our investigations, we found 1-Au to
be cytotoxic and cytostatic to cisplatin-resistant cancer cell lines.
Two methods for the preparation of gold(III) corroles have been
reported: [ClAu(tht)] (tht = tetrahydrothiophene) was used for inser-
tion into a b-brominated corrole in 85% yield,16 whereas Au(OAc)3
was utilized for the synthesis of several b-unsubstituted gold(III)
triarylcorroles in 25–35% yield.17 The above reagents, as well as
chloroauric acid and its salts were tested in an attempted synthesis
of 1-Au, but only gold(III) acetate led to the desired complex. The
treatment of 2,17-bis-sulfonato-5,10,15-trispentafluorophenylcorrole
(1-H3) with excess of Au(OAc)3 in pyridine at room temperature
allowed the isolation of 1-Au in 25% yield (Scheme 1).21
Scheme 1 Synthesis of 1-Au and previously reported metal complexes
of 1-H3.
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The electronic spectrum of 1-Au is similar to those of other
metal complexes of the same corrole (Fig. 1a); and, as expected, the
1H NMR spectrum displays two singlets (at 10.19 and 9.16 ppm),
assigned to the C3–H and C18–H protons adjacent to the sulfonic
acid moieties. Analysis of the 19F-NMR spectrum (Fig. 2) reveals
that the F atoms above and below the macrocycle plane experience
identical magnetic environments: each of three different C6F5
groups contributes only one chemical shift for the ortho- and
meta-F’s that it contains. The apparent relatively high symmetry
and the diamagnetism of 1-Au are fully consistent with expecta-
tions for the existence of a square planar low-spin 5d8 gold(III)
complex. MS spectroscopy further confirmed the structure and the
low affinity of axial ligands, as indicated by the molecular mass
without any additives from coordinating solvents (pyridine,
methanol, ethyl acetate) that were used in the synthesis and
for chromatographic purification.
Examination of 1-Au in aqueous PBS and PBS/glutathione
solutions revealed no changes in the far visible spectrum with
time, which is one indication that it has the stability required
to be considered as a drug candidate. Four NCI60 cell lines,
representative of breast, prostate, skin, and melanoma cancers,
were selected for investigations of 1-Au treatments for their
survival (by the MTS assay) and proliferation (by the BrdU
assay).22 Interestingly, 1-Au was found to possess 3.3 to 10.0-
fold greater cytotoxicity than that of 1-Ga (Fig. 3a and b) across all
four cancer cell lines. The cytotoxicity of 1-Au also was greater
than that of cisplatin in the prostate, skin, and melanoma cancer
cell lines (Table 1). Cytostatic activity also was examined for the
two corroles: that of 1-Au was 4.3 to more than 13.8-fold larger
than that for 1-Ga across all four cancer cell lines (Fig. 3c and d
and Table 2), clearly showing that 1-Au inhibits DNA replication
far more than 1-Ga. The striking similarity in the MTS and BrdU
IC50 values for 1-Au further suggests that the dominant mecha-
nism of cell-killing by 1-Au is through cell cycle arrest, a result of
DNA replication inhibition. Our proposed mechanism for 1-Au is
well-supported by our previous work that showed late M cell cycle
arrest across several diﬀerent cell lines by 1-Ga, 1-Al and 1-Mn.23
Extensive studies conducted on 1-Ga demonstrated the
importance of its spontaneous noncovalent conjugation with
proteins (owing to the amphipolar nature of themacrocycle), which
serves for both its circulation and assisted cell membrane penetra-
tion. In order to gain insight into why the gold(III) corrole performs
better than its gallium analogue, we examined its interaction with
human serum albumin. First we employed circular dichroism (CD),
since a signal in the visible range will only be obtained if 1-Au
conjugates with HSA and thus experiences a chiral environment.
A strong signal was obtained upon titration of 1-Au with HSA,
with a positive Cotton eﬀect and ellipticity inversion at 420 nm
(Fig. 1b).24 No change in the shape of the signal accompanied
Fig. 1 (a) Absorption spectrum of 1-Au. (b) Changes in the CD spectra of 1-Au,
with increasing amounts of HSA. [1-Au] = 5.0 105 M, [HSA] = 0–5 105 M.
Fig. 3 Dose–response cytotoxicity and cytostaticity curves for 1-Au (a, c) and
1-Ga (b, d), presented as percentages relative to cells treated in a corrole-free
medium with the same concentration of DMSO (1%) used for dissolving the
corroles.
Table 1 Comparison of IC50 cytotoxicity values of 1-Au, 1-Ga and
cisplatin in human cancer cell lines
Cell line DU145 SK-MEL-28 MDA-MB-231 OVCAR-3
Tumor type Prostate Melanoma Breast Ovarian
IC50 (mM) 1-Au 47.9 26.8 19.7 27.5
1-Ga 158.9 131.4 129.2 274.2
Cisplatin 81.0 36.8 44.8 22.8
Table 2 Comparison of IC50 cytostaticity values for 1-Au and 1-Ga
Cell line DU145 SK-MEL-28 MDA-MB-231 OVCAR-3
IC50 (mM) 1-Au 68.5 35.6 75.1 25.4
1-Ga 4350.0 201.9 322.5 4350.0
Fig. 2 19F NMR spectrum of 1-Au, in CD3OD.
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the titration, quite unlike our observations in related CD experiments
where we found that 8–10 equivalents of 1-Ga bind to HSA.15
Additional evidence for marked diﬀerences in binding aﬃ-
nities of the two corroles was obtained upon quenching of the
fluorescence of the only tryptophan residue present in HSA by
1-Au and 1-Ga (Fig. 4a and b, respectively).
The comparison clearly demonstrates that the aﬃnity of
1-Au for HSA (or more precisely to binding sites that are close to
Trp214) is much lower than that of 1-Ga. At the highest corrole/
HSA ratio, the Trp214 emission was completely quenched for
1-Ga (the residual emission is due to tyrosines), but not for 1-Au.
Another qualitative indication of the weaker binding of 1-Au
was obtained by mass spectroscopy.25 Analysis of the ESI-MS
spectra of 1 : 6 solutions of HSA and the corrole revealed that
molecular clusters that correspond to HSA-bound conjugates
were much more pronounced for 1-Ga than 1-Au (Fig. 5). The
relatively weak binding of 1-Au to albumin (present in the in vitro
assays used for evaluating its cytotoxicity and cytostaticity) could
be one of the factors contributing to its higher activity relative to
1-Ga. The low aﬃnity of 1-Au for basic amino acid residues means
that a more uncomplexed agent will likely be available for inter-
vention in intracellular processes. In support of this proposal,
several investigators have shown that the interactions of many
metallodrugs (including cisplatin and gold(III) pyridyls) with albumin
are a major influence on their biological activities.26–28
We have discovered that 1-Au is a more potent anticancer
agent than 1-Ga, with three to ten-fold greater cytotoxicity and
four to more than ten-fold greater cytostaticity in four cancer
cell lines. In our hands, 1-Au also exhibited greater cytotoxicity
than cisplatin in three out of the four cell lines examined.
We suggest that the diminished binding of 1-Au to HSA relative
to 1-Ga is responsible for its greater cell killing ability. The
correlation between cytotoxicity and cytostaticity further sug-
gests that the main mechanism of action is viamitotic arrest, as
established for other metal complexes of the same corrole.23
Although the anticancer potency of 1-Au is not as great as that
of [Au(TPP)]Cl, it is substantially more cytotoxic than water-
soluble gold(III) porphyrins.29 The take-home lesson is clear: wemust
place much more emphasis on investigations of less hydrophilic
corroles in our search for better anticancer agents. More in-depth
investigations of the mechanism of action of the most active gold
corroles, as well as exploration of their potential for photodynamic
therapy,30 will be pursued in these derivatives.
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Undergraduate Research Fellowship program (D.R.T.).
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